• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD (SUZHOU) BD INTIMA-II CLOSED IV CATHETER SYSTEM; INTERVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD (SUZHOU) BD INTIMA-II CLOSED IV CATHETER SYSTEM; INTERVASCULAR CATHETER Back to Search Results
Catalog Number 383083
Device Problem Leak/Splash (1354)
Patient Problem Extravasation (1842)
Event Date 10/09/2020
Event Type  Injury  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that 5 bd intima-ii¿ closed iv catheter systems experienced leakage during use.The product defect resulted in drug extravasation into the patient's surrounding tissues.The patient received medical intervention/treatment as a result.No information regarding the patient's final outcome are currently available.The following information was provided by the initial reporter: the needle hole at insertion site after the withdrawal of the needle was large, and the drugs were extravasated.Two needles were kept in the same batch, and the five affected hospitals had been treated additional information received as follows: the patient¿s hand phlebitis was after needle extraction, which had nothing to do with the quality of the needle.In the ankle patient, redness was found at the puncture site on 7th, which was estimated to be caused by the drug solution permeating to the surrounding tissues, and vb6 was injected.It was slightly acidic and belonged to irritant drugs.
 
Manufacturer Narrative
Investigation summary a device history review was conducted for lot number 9262090.Our records show that this is the only instance of this issue occurring in this production batch.According to the sampling plan applied for product performance, this lot was accepted and released without defects being noted during the final assembly or visual inspections.Based on the provided photographs of the insertion sight our engineers believe that the leakage occurred as a result of localized inflammation.This lot was treated and received a certificate of conformance for sterility; additional causes for the observed inflammation can occur independent of the manufacturing process.
 
Event Description
It was reported that 5 bd intima-ii¿ closed iv catheter systems experienced leakage during use.The product defect resulted in drug extravasation into the patient's surrounding tissues.The patient received medical intervention/treatment as a result.No information regarding the patient's final outcome are currently available.The following information was provided by the initial reporter: the needle hole at insertion site after the withdrawal of the needle was large, and the drugs were extravasated.Two needles were kept in the same batch, and the five affected hospitals had been treated additional information received as follows: 1.The patient¿s hand phlebitis was after needle extraction, which had nothing to do with the quality of the needle 2.In the ankle patient, redness was found at the puncture site on 7th, which was estimated to be caused by the drug solution permeating to the surrounding tissues, and vb6 was injected.It was slightly acidic and belonged to irritant drugs.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INTIMA-II CLOSED IV CATHETER SYSTEM
Type of Device
INTERVASCULAR CATHETER
Manufacturer (Section D)
BD (SUZHOU)
no. 5 baiyu road
suzhou industrial park
suzhou
MDR Report Key10774985
MDR Text Key214332038
Report Number3006948883-2020-00673
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 11/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date10/26/2022
Device Catalogue Number383083
Device Lot Number9262090
Was Device Available for Evaluation? No
Date Manufacturer Received11/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-